Диссертация (1139658), страница 43
Текст из файла (страница 43)
– Р. E1763–E1773.417.Starke, J. R. Interferon-release assays for the diagnosis of tuberculosisinfection in children / J. R. Starke // J. Pediatr. – 2012. – Vol. 161. – P. 581–582.418.Stenger, S. T cell mediated immunity to Mycobacterium tuberculosis / S.Stenger, R. L. Modlin // Curr. Opin.Microbiol. – 1999. – № 2. – P. 89–93.419.Stokes, R. W. Adjusting to a new home: Mycobacterium tuberculosis geneexpression in response to an intracellular lifestyle / R.
W. Stokes, S. J. Waddel //Future Microbiol. – 2009. – Vol. 4. – P. 1317-1335.420.Suppression of human IL-1beta, IL-2, IFN-gamma, and TNF-alphaproduction by cigarette smoke extracts / Y. Ouyang [et al.] // J. Allergy Clin.Immunol. – 2000. – Vol. 106, № 2. – P. 280–287.421.T cells and adaptive immunity to Mycobacterium tuberculosis in humans /L. D. Jasenosky [et al.] // Immunol. Rev. – 2015. – № 264, № 1. – Р. 74-87.422.Targeting multiple response regulators of Mycobacterium tuberculosisaugments the host immune response to infection [Electronic resource] / S. K.Banerjee [et al.] // Scientific Reports.
– 2016. – Vol. 6. – P. 25851. –DOI:10.1038/srep25851.423.T-cell exhaustion in tuberculosis: pitfalls and prospects / N. Khan [et al.] //Crit. Rev. Microbiol. – 2017. – Vol. 43, 2. – P. 133-141.424.T-cell interferon- release assays for the rapid immunodiagnosis oftuberculosis: clinical utility in high-burden vs. low-burden settings / K. Dheda [etal.] // Curr. Opin. Pulm. Med.
– 2009. – Vol. 15, № 3. – P. 188–200.425.Th1 and Th2 cytokines and IgE levels in identical twins with varying levelsof cigarette consumption / W. Cozen [et al.] // J. Clin. Immunol. – 2004. – Vol.24, № 6. – P. 617–622.249426.The 14,000-molecular-weight antigen of Mycobacterium tuberculosis isrelated to the alpha-crystallin family of Iow-molecular-weight heat shock proteins/ A. Verbon [et al.] // J. Bacteriol. – 1992. – Vol. 174. – P. 1352-1359.427.The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosisis required for growth in macrophages / Y.
Yuan [et al.] // Proc. Nat. Acad. Sci.USA. – 1998. – Vol. 95. – P. 9578-9583.428.The eradication of tuberculosis infection by isoniazid chemoprophylaxis /V. N. Houk [et al.] // Arch. Environ. Health. – 1968. – Vol. 16, № 1. – P. 46–50.429.The global tuberculosis epidemic and progress in care, prevention, andresearch: an overview in year 3 of the End TB era / K. Floyd [et al.] // LancetRespir. Med.
– 2018. – Vol. 6, issue 4. – P. 299–314.430.The human immune response to tuberculosis and its treatment: a view fromthe blood / J. M. Cliff [et al.] // Immunol. Rev. – 2015. – Vol. 264, № 1. – P. 88102.431.The Mycobacterium tuberculosis dosRS two-component system is inducedby multiple stresses / S. L. Kendall [et al.] // Tuberculosis (Edinb).
– 2004. – Vol.84. – P. 247-255.432.The Mycobacterium tuberculosis PhoPR two component system regulatesgenes essential for virulence and complex lipid biosynthesis / S. B. Walters [etal.] // Mol. microbiol. –2006. – Vol. 60. – P. 312-330.433.The Mycobacterium tuberculosis complex-restricted gene CFP32 encodesan expressed protein that is detectable in tuberculosis patients and is positivelycorrelated with pulmonary interleukin-10 / R.
C. Huard [et al.] // Infect. Immun. –2003. – Vol. 71. – P. 6871-6883.434.The mycolyltransferase 85A, a putative drug target of Mycobacteriumtuberculosis: development of a novel assay and quantification of glycolipid-statusof the mycobacterial cell wall / A. A. Elamin [et al.] // J. Microbiol. Methods. –2009. – Vol. 79, № 3. – P. 358–363.435.The prognosis of latent tuberculosis: can disease be predicted? / Р.Andersen [et al.] // Trends. Mol. Med. – 2007. – Vol. 13, № 5.
– P. 175-182.250436.The pros and cons of the QuantiFERON test for the diagnosis oftuberculosis, prediction of disease progression, and treatment monitoring / E. N.Ndzi [et al.] / Int. J. Micobacteriol. –2016. – Vol. 5, № 2. – P. 177-184.437.The RD1 locus in the Mycobacterium tuberculosis genome contributes toactivation of caspase-1 via induction of potassium ion efflux in infectedmacrophages / T. Kurenuma [et al.] // Infect. Immun. – 2009. – Vol. 77, № 9. – Р.3992–4001. – doi: 10.1128/IAI.
00015-09.438.The resuscitation-promoting factors of Mycobacterium tuberculosis arerequired for virulence and resuscitation from dormancy but are collectivelydispensable for growth in vitro / B. D. Kana [et al.] // Mol. Microbiol. – 2008. –Vol. 67. – P. 672-684.439.The spectrum of disease in children treated for tuberculosis in a highlyendemic area / B. J. Marais [et al.] // Int.
J. Tuberc. Lung Dis. – 2006. – Vol. 10.– P. 732–738.440.The spectrum of latent tuberculosis: rethinking the biology and interventionstrategies / C. E. Barry III [et al.] // Nat. Rev. Microbiol. – 2009. – Vol. 7, № 12.– P. 845–855.441.The Mycobacterium bovis BCG prime-Rv0577 DNA boost vaccinationinduces a durable Th1 immune response in mice / D.
Gu [et al.] // Acta Biochim.Biophys. Sin (Shanghai). – 2016. – Vol. 48, № 4. – P. 385-390.442.Tietz textbook of clinical chemistry and molecular diagnostics / ed. C. A.Burtis, E. R. Ashwood, D. E. Bruns. – 4 ed. – New Delhi : Elsevier, 2006. – 2412p.443.TLR2-dependentmastcellactivationcontributestothecontrolofMycobacterium tuberculosis infection / D. Carlos [et al.] // Microbes Infect.
–2009. – Vol. 11. – P. 770–778.444.Tobacco smoking increases immune activation and impairs T-cell functionin HIV infected patients on antiretrovirals: a cross-sectional pilot study / R.Valiathan [et al.] // PLoS One. – 2014. – Vol. 9, № 5.
– e97698.251445.Toll-Like receptor 2 is required for control of pulmonary infection withFrancisella tularensis / M. Malik [et al.] // Infect. Immunity. – 2006. – Vol. 74,№ 6. – P. 3657-3662.446.Toll-like receptors control activation of adaptive immune responses / M.Schnare [et al.] // Nat. Immunol.
– 2001. – Vol. 2, № 10. – P. 947–950.447.Topham, N. J. Natural killer cell cytotoxicity: how do they pull the trigger?/ N. J. Topham, E. W. Hewitt // Immunology. – 2009. – № 1. – P. 7–15.448.Tracking universal health coverage. First global monitoring report[Electronic resource] / World Health Organization, The World Bank. – Geneva :WHO,–2015.URL:http://apps.who.int/iris/bitstream/handle/10665/174536/9789241564977_eng.pdf.449.TranscriptionalAdaptationofMycobacteriumtuberculosiswithinMacrophages: insights into the phagosomal environment / D.
Schnappinger [etal.] // J. Exp. Med. – 2003. – Vol. 198. – P. 693-704.450.Transgenerational effects of prenatal nutrient restriction on cardiovascularand hypothalamic-pituitary-adrenal function / C. Bertram [et al.] // J. Physiol. –2008. – Vol. 586, № 8. – P. 2217–2229.451.Travar, M. Type I, II, and III interferons: regulating immunity toMycobacterium tuberculosis infection / M. Travar, M. Petkovic, A. Verhaz //Arch. Immunol.
Ther. Exp. (Warsz). – 2016. – Vol. 64, № 1. – P. 19-31. – doi:10.1007/s00005-015-0365-7.452.Treatment of latent tuberculosis infection in HIV infected persons[Electronic resource] / C. Akolo [et al.] // Cochrane Database Syst Rev. – 2010. –Vol. 20, issue 1. – CD000171.453.Triggering through Toll-like receptor 2 limits chronically stimulated T-helper type 1 cells from undergoing exhaustion / S. B.
Chodisetti [et al.] // J.Infect. Dis. – 2015. Vol. 211. – P. 486–496.454.Trunz, B. B. Effect of BCG vaccination on childhood tuberculousmeningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of252cost-effectiveness / B. B. Trunz, P. Fine, C. Dye // Lancet. – 2006. – Vol. 367, №9517.
– P. 1173–1180.455.Tuberculin reactivity after newborn BCG immunization in mono- anddizygotic twins / R. L. Sepulveda [et al.] // Tuber. Lung Dis. – 1994. – Vol. 75. –P. 138–143.456.Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent / J. Keane [et al.] // N.
Engl. J. Med. – 2001. – Vol. 345, № 15.– P. 1098–104.457.Tuberculosis disease diagnosis using artificial immune recognition system./ S. Shahaboddin [et al.] // Int. J. Med. Sci. – 2014. – Vol. 11, № 5. – P. 508e14.458.Tuberculosis fact sheet, 2017 [Electronic resousce] / World HealthOrganization. – URL: http://www.who.int/mediacentre/factsheets/fs104/en/.
–[Access date: 18.05.18].459.Tuberculosis genes expressed during persistence and reactivation in theresistant rabbit model / A. K. Kesavan [et al.] // Tuberculosis. – 2009. – Vol. 89.– P. 17-21.460.Tuberculosis immunology in children: diagnostic and therapeuticchallenges and opportunities / D. A. Lewinsohn [et al.] // Int.
J. Tuberc. Ling.Dis. – 2004. – Vol. 8, № 5. – P.658-674.461.Tuberculosis in children and adults: two distinct genetic diseases / A.Alcaïs [et al.] // J. Experim. Med. – 2005. – Vol. 202, № 12. – P. 1617-1621.462.Tuberculosis subunit vaccination provides long-term protective immunitycharacterized by multifunctional CD4 memory T cells / T. Lindenstrom [et al.] //J. Immunol. – 2009. – Vol. 182.
– P. 8047–8055.463.Tumor necrosis factor neutralization results in disseminated disease inacute and latent Mycobacterium tuberculosis infection with normal granulomastructure in a cynomolgus macaque model / P. L. Lin [et al.] // Arthritis Rheum. –2010. – Vol. 62, № 2. – P. 340–350.464.Type I interferons mediate the innate cytokine response to recombinantFowlpox virus but not the induction of plasmacytoid dendritic cell-dependent253adaptive immunity / E. L. Lousberg [et al.] // Journal of Virology. – 2010. – Vol.84, № 13. – Р. 6549–6563.
– doi: 10.1128/JVI.02618-09.465.Ulrichs, T. New insights into the function of granulomas in humantuberculosis / T. Ulrichs, S. H. Kaufmann // J. Pathol. – 2006. – Vol. 208. – P.261-269.466.Understanding delayed T-cell priming, lung recruitment, and airwayluminal T-cell responses in host defense against pulmonary tuberculosis[Electronic resource] / C. R. Shaler [et al.] // Clin. Dev. Immunol. – 2012. – DOI:10.1155/2012/628293.467.Update on tuberculosis biomarkers: from correlates of risk, to correlates ofactive disease and of cure from disease / D. Goletti [et al.] // Respirology. – 2018.– Vol. 23, № 5. – P.
455-466.468.Using the TBAg/PHA ratio in the T-SPOT(®).TB assay to distinguish TBdisease from LTBI in an endemic area / F. Wang [et al.] // Int. J. Tuberc. LungDis. – 2016. – Vol. 20, № 4. – P. 487-493.469.van Crevel, R. Innate Immunity to Mycobacterium tuberculosis / R. VanCrevel, T. H. Ottenhoff, J. W. Van der Meer // Clin. Microbiol. Rev.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
